Anavex Life Sciences Corp (AVXL)

[Investor2014]

Fascinating subject Master Protocol clinical trial design.

Here is another very recent paper with many hints that seem to match with Anavex evolving a Precision Medicine focus:

Basket trials in oncology have provided an alternative pathway to new drug approvals in the era of personalized medicine. Cancer may not be the only disease that can benefit from alternative trial design. Diseases having genetic components may also benefit from this trial design. There is certainly a new horizon for this alternative, yet complex trial design. Educating research practitioners on core competencies in clinical research, including an understanding of genomics, in addition to an emphasis on team science and communication, will prepare sites to meet this new challenge.

http://www.centerwatch.com/news-online/2017/06/01/post-august-changes-oncology-treatments-may-lead-changes-clinical-trial-design-overview-basket-trial-progress/